MARKET

MITO

MITO

Stealth BioTherapeutics
NASDAQ

Real-time Quotes | Nasdaq Last Sale

6.46
-0.45
-6.51%
Opening 15:31 10/16 EDT
OPEN
7.26
PREV CLOSE
6.91
HIGH
7.26
LOW
6.46
VOLUME
20.44K
TURNOVER
--
52 WEEK HIGH
20.99
52 WEEK LOW
4.970
MARKET CAP
213.30M
P/E (TTM)
-0.8184
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of MITO and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

MITO News

  • Stealth BioTherapeutics Does The Deal With Alexion, And Other Headlines: The Good, Bad And Ugly Of Biopharma
  • Seeking Alpha - Article.3d ago
  • A Look At Benzinga Pro's Most-Searched Tickers For October 11, 2019
  • Benzinga.5d ago
  • Company News For Oct 11, 2019
  • Zacks.5d ago
  • Alexion (ALXN) Collaborates With Stealth BioTherapeutics
  • Zacks.5d ago

More

Industry

Biotechnology & Medical Research
+0.14%
Pharmaceuticals & Medical Research
+0.06%

Hot Stocks

Name
Price
%Change

About MITO

Stealth BioTherapeutics Corp. is a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction. The Company is primarily focused on developing mitochondrial targeted therapies for diseases with clear unmet medical needs including cardiovascular, renal, neurodegenerative and metabolic diseases. The Company is engaged in developing its product pipelines, which include Elamipretide, SBT-20 and SBT-272.
More

Webull offers Stealth BioTherapeutics Corp (MITO) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.